Regenerative medicine investors
8 investors that name Regenerative medicine among their sectors are recorded here: 3 venture capital firms, 2 corporate venture arms, 2 other investors and 1 private equity firm. Stated investment stages run from pre-seed to buyout. Most are headquartered in Belgium (1), Canada (1) and Germany (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| Boehringer Ingelheim Venture Fund Cancer · Regenerative medicine · Auto-immunity · Digital solutions |
Direct + LP | Corporate venture | Seed – Series A | Ingelheim, Germany |
| CCRM Enterprises Holdings gene-editing technologies · gene-modified cell therapies · delivery vehicles · regenerative medicine |
Direct investor | Other | Pre-seed – Seed | Toronto, Canada |
| Dynamk Capital Life Science Industrials · biotechnology · cell and gene therapies · vaccines |
Direct investor | Venture capital | Not stated | New York, United States |
| Korify Capital longevity · mental health · regenerative medicine · biotechnology |
Direct investor | Venture capital | Series A – Series C+ | |
| Medical Excellence Capital gene therapy · cell therapy · synthetic biology · regenerative medicine |
Direct investor | Venture capital | Seed – Series B | |
| SBI Shinsei Corporate Investment Limited IT · Deep Tech · healthcare · manufacturing |
Direct investor | Private equity | Seed – Buyout | Tokyo, Japan |
| Shuimu Group (水木集團) new energy · high-end equipment · biomedicine · industrial software |
Direct investor | Other | Not stated | Hong Kong, Hong Kong SAR China |
| UCB Ventures next-generation cell and gene therapy · regenerative medicine · cell and tissue homeostasis · RNA modulation |
Direct + LP | Corporate venture | Seed – Series A | Brussels, Belgium |